04/02/2026
New Insights into Fibromyalgia Cognitive Dysfunction ๐ง ๐ฌ
A pioneering study has revealed significant links between hippocampal dysfunction in fibromyalgia and markers of bacterial and viral infections ๐ฆ , alongside elevated anti-CCP antibodies. These findings provide compelling evidence of a biological basis for โfibro fog,โ highlighting the potential role of immune and infectious mechanisms in cognitive symptoms and suggesting new pathways for assessment and clinical management.
The study is co-published by Dr. Armin Schwarzbach, PhD, MD, a globally recognised expert in laboratory medicine and tick-borne diseases ๐ฉบ, and a distinguished member of the AONM advisory panel. His expertise has informed numerous webinars and research initiatives, reinforcing AONMโs commitment to advancing scientific understanding and patient care in complex chronic conditions.
๐ Explore the full study here:
On the basis of this study, it is suggested that, in fibromyalgia patients complaining of dyscognition, there may be merit in assessing lymphocyte function-associated antigen-1, anti-CCP IgG, and evidence of infection with Borrelia species, Ehrlichia chaffeensis, Anaplasma phagocytophilum, Mycoplasm...